Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes

Diabetes Care. 2022 Sep 1;45(9):126-128. doi: 10.2337/dc22-0659.

Authors

Klara R Klein¹, Virginia Pate², Magdalene M Assimon³, Til Stürmer², John B Buse¹, Jennifer E Flythe^{3

4}

Affiliations

¹ Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, NC.
² Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
³ Division of Nephrology and Hypertension, University of North Carolina School of Medicine, Chapel Hill, NC.
⁴ Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Letter

MeSH terms

Adult
Comorbidity
Diabetes Mellitus, Type 2* / epidemiology
Humans
Hypoglycemic Agents / therapeutic use
Kidney Diseases* / drug therapy
Renal Dialysis

Substances

Hypoglycemic Agents

Grants and funding

R01 HL152034/HL/NHLBI NIH HHS/United States